Answers are grounded in this paper and cite their sources.
Longitudinal study finds poor clearance of circulating cathodic antigen in children with schistosomiasis, suggesting need for better diagnostic methods.
Background: Praziquantel (PZQ) remains the primary drug for treating schistosomiasis, with its efficacy traditionally measured using the Kato-Katz technique. However, these methods have limitations, prompting interest in point-of-care circulating cathodic antigen (POC-CCA) tests as an alternative diagnostic tool. This study aimed to assess the efficacy of praziquantel in clearing circulating cathodic antigen (CCA) among pre- and school-aged children in a S. mansoni hyper-endemic area of North-Western Tanzania. Methods: A longitudinal study was conducted among 161 children aged 2–17 years. Participants were screened for S. mansoni infection using Kato-Katz and POC-CCA tests at baseline and 21 days post-treatment with a single dose of PZQ (40 mg/kg). Cure rates (CR) and egg reduction rates (ERR) were calculated. Results: The overall prevalence of S. mansoni was 98 (70.0%) (Kato-Katz) and 114 (70.8%) (POC-CCA). The parasitological cure rate (PCR) was 61 (66.3%) (Kato-Katz) and 27 (27.6%) (POC-CCA), with an ERR of 73.6%. Significant differences were observed between the two diagnostic methods. Conclusion: While PZQ demonstrated adequate efficacy based on Kato-Katz results, poor CCA clearance highlights the need for improved diagnostics and monitoring strategies in schistosomiasis control programs.
No takes yet. Share an insight, caveat, or question.
Zabron et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: